NCT05334004View on ClinicalTrials.gov

Lopinavir/Ritonavir in PLWH With High-Grade AIN

PHASE1RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
High-Grade Anal Intraepithelial Neoplasia
Interventions
DRUG

Lopinavir / Ritonavir

Human Immunodeficiency Virus (HIV) antiviral, given via suppository

Trial Locations (1)

53705

RECRUITING

UW Digestive Health Center Anoscopy Clinic, Madison

All Listed Sponsors
collaborator

Wisconsin Partnership Program

OTHER

lead

University of Wisconsin, Madison

OTHER